
1. Rev Soc Bras Med Trop. 2021 Nov 12;54:e0385. doi: 10.1590/0037-8682-0385-2021.
eCollection 2021.

Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A 
case report.

Menegali BT(1)(2), Schuelter-Trevisol F(1)(2), Barbosa AN(3), Izidoro TM(2),
Feurschuette OHM(2), Marcon CEM(1)(2), Trevisol DJ(1)(2).

Author information: 
(1)Universidade do Sul de Santa Catarina, Programa de Pós-Graduação em Ciências
da Saúde, Tubarão, SC, Brasil.
(2)Universidade do Sul de Santa Catarina, Faculdade de Medicina, Tubarão, SC,
Brasil.
(3)Universidade do Estado de São Paulo, Departamento de Doenças Infecciosas,
Botucatu, SP, Brasil.

The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports
on the first cases of newborns with antibodies to sudden acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using
immunizations with inactivated viruses. Thus, this study aimed to report a case
of passive anti-SARS-CoV-2 immunity in a newborn through immunoprophylaxis of a
pregnant woman who received the CoronaVac® vaccine in the third trimester of
pregnancy. Twenty-four hours after delivery, samples were collected from the
newborn and screened by enzyme immunoassays, which revealed antibodies to
SARS-CoV-2.

DOI: 10.1590/0037-8682-0385-2021 
PMCID: PMC8582956
PMID: 34787263  [Indexed for MEDLINE]

